---
title: "Invivyd, Inc. (IVVD) Discusses Progress in REVOLUTION Clinical Program and Advancement of Measles Monoclonal Antibody Candidate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282283900.md"
description: "Invivyd, Inc. (IVVD) has released a slide deck discussing the progress of its REVOLUTION Clinical Program. The company also highlighted the advancement of its measles monoclonal antibody candidate. This information is presented in a slideshow format for investors."
datetime: "2026-04-10T03:40:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282283900.md)
  - [en](https://longbridge.com/en/news/282283900.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282283900.md)
---

# Invivyd, Inc. (IVVD) Discusses Progress in REVOLUTION Clinical Program and Advancement of Measles Monoclonal Antibody Candidate

Invivyd, Inc. (IVVD) has released a slide deck discussing the progress of its REVOLUTION Clinical Program. The company also highlighted the advancement of its measles monoclonal antibody candidate. This information is presented in a slideshow format for investors.

### Related Stocks

- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [IVVD.US](https://longbridge.com/en/quote/IVVD.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [Relay drug shows early promise against rare blood vessel diseases](https://longbridge.com/en/news/287094432.md)
- [Eton Pharmaceuticals Adds Another 2026 Launch As It Secures U.S. Rights To IMPAVIDO](https://longbridge.com/en/news/287025596.md)
- [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md)
- [<![CDATA[Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates]]>](https://longbridge.com/en/news/286787081.md)
- [<![CDATA[Pharmaceutical Executive Daily: FDA Approves Baxdrostat]]>](https://longbridge.com/en/news/286807703.md)